Amphastar Pharmaceuticals Stock Forecast
NASDAQ: AMPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 9:31 AM ET
AMPH analyst consensus
Consensus (7 analysts)
none
Avg. price target
$22.50-11.23%
- Strong buy 0
- Buy 0
- Hold 6
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Amphastar Pharmaceuticals (2026-10-08), 0 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $22.50, with a high estimate of $30.00 and a low estimate of $20.00. The average target implies downside of 11.2% from the current price of $25.35.
The spread between the highest and lowest targets is 50.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for AMPH.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 6 | 86% |
| Sell | 0 | 0% |
| Strong sell | 1 | 14% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $20.00 | -21.09% |
| Average target | $22.50 | -11.23% |
| High target | $30.00 | +18.37% |